Syschem India Ltd
Pursuant to regulation 47 of SEBI LODR(Listing Obligations and Disclosure requirement), 2015.
Syschem India Ltd has published newspaper advertisements for its 33rd Annual General Meeting (AGM) to be held through video conferencing.
20
total announcements
531173.BO · 15 min delayed
Syschem India Ltd
Syschem India Ltd has published newspaper advertisements for its 33rd Annual General Meeting (AGM) to be held through video conferencing.
Syschem India Ltd
Syschem India Ltd has announced its 33rd Annual General Meeting, where shareholders will consider and adopt the audited financial statement for FY 2025-26, appoint a director, and approve the appointment of a new auditor. The company will also consider the approval of material related party transactions with M/S Pharmacare International for a period of one year.
Syschem India Ltd
Syschem India Ltd has announced its Annual Report for FY 2025-26, along with the Notice of 33rd Annual General Meeting (AGM) to be held on September 30, 2026. The report includes the audited financial statements, reports of the Board of Directors and Auditors, and resolutions for the AGM.
Syschem India Ltd
Syschem India Ltd has published newspaper advertisements as per regulation 47 of SEBI(Listing Obligations and Disclosure Requirements), 2015, regarding the 33rd Annual General Meeting (AGM) to be held through video conferencing.
Syschem India Ltd
Syschem India Ltd has announced the resignation of its statutory auditor, STAV & Co., due to the expiration of their Peer Review Certificate on 31st August 2026, which has not been renewed.
Syschem India Ltd
Syschem India Ltd clarifies the proposed fee and terms of appointment of statutory auditor in their board meeting dated 01.09.2026.
Syschem India Ltd
Syschem India Ltd has announced the approval of its Annual General Meeting date, Book closure, and other board decisions, including the appointment of new directors and auditors.
Syschem India Ltd
Syschem India Ltd has announced the outcome of its Board Meeting, which included the appointment of a new Statutory Auditor, M/s Bansal Vijay & Associates, and the re-designation of Mr. Suninder Veer Singh as Managing Director and Mr. Ranjan Jain as Whole-Time Director, subject to shareholder approval.
Syschem India Ltd
Syschem India Ltd has announced the outcome of its board meeting held on September 1, 2026. The board approved the appointment of new directors, including Mr. Suninder Veer Singh as Managing Director and Mr. Ranjan Jain as Whole-Time Director. The board also approved the appointment of new statutory auditors, M/s Bansal Vijay & Associates, and noted the resignation of the previous statutory auditor, M/s STAV & Co, due to the expiration of their Peer Review Certificate.
Syschem India Ltd
Syschem India Ltd has announced the resignation of its Statutory Auditor, M/s STAV & Co., due to the expiry of their Peer Review Certificate. The auditor has tendered their resignation with effect from 31 August 2026, and the company is in the process of appointing a new auditor.
Syschem India Ltd
Syschem India Ltd clarifies that an inadvertent typographical error in its investor presentation uploaded on August 8, 2026, incorrectly referred to 'Q2 (Quarter-2)' as 'Q1 (Quarter-1)', stating that the error is purely typographical and does not affect financial figures or disclosures.
Syschem India Ltd
Syschem India Ltd presented its 2nd quarter results for FY26-27, showing a moderate revenue and EBITDA performance due to challenging market environment and global economic uncertainties. The company maintained operational efficiency and focused on cost optimization and strengthening its market position.
Syschem India Ltd
Syschem India Ltd has published unaudited financial results for the quarter ended June 30, 2026, which have been considered approved and taken on record by the Board of Directors. The results were published in newspapers Jansatta (Hindi) and Financial Express (Chandigarh and Delhi) on August 5, 2026.
Syschem India Ltd
Syschem India Ltd clarifies that 31,97,500 Convertible Warrants out of 1,67,00,000 allotted on 04 Feb 2025 lapsed due to non-exercise within 18 months, resulting in forfeiture of upfront subscription amount.
Syschem India Ltd
Syschem India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has also informed about the lapse of convertible warrants and forfeiture of upfront consideration. The company's board of directors has approved the unaudited financial results, which have been reviewed by the statutory auditor. The convertible warrants, which were allotted on a preferential basis in February 2025, have lapsed as the allottees failed to exercise their option to convert them into equity shares within the stipulated period.
Syschem India Ltd
Syschem India Ltd has announced its Q1 2026 results, with the Board of Directors approving the unaudited financial results for the quarter ended June 2026. The company has also forfeited 66 million warrants due to non-exercise by allottees, resulting in a loss of Rs. 391.69 lakhs.
Syschem India Ltd
Syschem India Ltd announced the lapse of convertible warrants on August 3, 2026, due to non-exercise by allottees. The company forfeited the upfront amount of Rs. 3,91,69,375. The board also approved unaudited financial results for the quarter ended June 30, 2026, along with a limited review report.
Syschem India Ltd
Syschem India Ltd has scheduled a board meeting on 04/08/2026 to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Syschem India Ltd
Syschem India Ltd allotted 2,50,000 equity shares of ₹10 each to 9 eligible employees at par, following the exercise of vested stock options under its ESOP Scheme_2024. This action increased the company's issued, subscribed, and paid-up equity share capital from ₹49.01 crore to ₹49.26 crore. The allotment generated ₹25 lakh for the company. These new shares will rank pari passu with existing equity shares, fostering employee ownership and slightly enhancing the capital base.
Syschem India Ltd
Syschem India Ltd's Board of Directors approved the allotment of 2,50,000 equity shares of face value ₹10 each to 9 eligible employees. These shares were allotted upon the exercise of vested stock options under the Company's ESOP Scheme_2024, generating ₹25,00,000 for the company. Consequently, the issued, subscribed, and paid-up equity share capital increased from ₹49,01,30,000 to ₹49,26,30,000, and the newly allotted shares will rank pari passu with existing equity shares.